NCT03086252 is a NA clinical trial of Red Blood Cell Transfusions (RBCT) in Anemia, sponsored by Emory University.

Who is sponsoring NCT03086252?

NCT03086252 is sponsored by Emory University.

What drugs are being tested in NCT03086252?

Interventions in NCT03086252: Red Blood Cell Transfusions (RBCT).

What condition does NCT03086252 study?

NCT03086252 studies Anemia, Aplastic Anemia, Bone Marrow Failure, Hematopoietic and Lymphoid Cell Neoplasm, Leukemia, Myelodysplastic Syndrome.

Is NCT03086252 still recruiting?

NCT03086252 is currently withdrawn. Last updated 26 July 2018.

Last reviewed 2018-07-26 · How we verify

NCT03086252

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study

Withdrawn NA Last updated 26 July 2018

What this trial tests

NA trial testing Red Blood Cell Transfusions (RBCT) in Anemia. Withdrawn.

Timeline

24 July 2017

Primary endpoint
31 May 2018

31 May 2018

Quick facts

Lead sponsor	Emory University
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Start date	24 July 2017
Primary completion	31 May 2018
Estimated completion	31 May 2018
Sites	1 location across United States

Drugs / interventions tested

Red Blood Cell Transfusions (RBCT)

Conditions studied

Anemia — all drugs for Anemia →
Aplastic Anemia — all drugs for Aplastic Anemia →
Bone Marrow Failure — all drugs for Bone Marrow Failure →
Hematopoietic and Lymphoid Cell Neoplasm — all drugs for Hematopoietic and Lymphoid Cell Neoplasm →

Sponsor

Emory University

Who can join

19 and older, any sex, with Anemia or Aplastic Anemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot study evaluates safety of administration of red blood cell transfusions requested by patients based on their symptoms instead of levels of hemoglobin for the treatment of chronic anemia in patients with blood disorders.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
Radford M, Estcourt LJ, Sirotich E, Pitre T, et al · · 2024 · cited 8× · PMID 38780066 · DOI 10.1002/14651858.cd011305.pub3

Verify or expand the search:

Other recruiting trials for Anemia

Currently open trials in the same condition.

NCT07422480 — A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myel · Phase 3 · recruiting
NCT06968936 — Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy · NA · recruiting
NCT07328191 — Quality of Life-Guided Transfusion in Refractory MDS or AML · NA · recruiting
NCT07315295 — Maximizing the Benefits of Iron in Ready-to-Use Therapeutic Foods for Malnourished Children in Kenya · NA · recruiting
NCT07400796 — Assessing Health System Readiness for Scaling Antenatal MMS in Cambodia · recruiting

Other Emory University trials

Trials by the same sponsor.

NCT06143345 — HIIT in Isolated IFG: A Proof-of-Concept Study · NA · withdrawn
NCT07189819 — Innovative Closed-loop Functional Electrical Stimulation Control System for Augmenting Post-stroke Gait · NA · not yet recruiting
NCT06451055 — Low-calorie Diet in Isolated Impaired Fasting Glucose · NA · not yet recruiting
NCT07405476 — Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative I · Phase 2 · recruiting
NCT06708351 — Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03086252 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Emory University
Last refreshed: 26 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03086252.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing